Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Phase I/II enrollment completed for HuMax-IL-15 in rheumatoid arthritis

June 3, 2002

Genelabs expects Aslera NDA response by August 2002

May 30, 2002

Nikken Chemicals patents TNF-alpha production inhibitors

May 30, 2002

MRA completes phase II trial in rheumatoid arthritis

May 29, 2002

PDE7 inhibitors useful for T-cell-related conditions

May 28, 2002

Novel metalloproteinase inhibitors designed at DuPont

May 28, 2002

Discovery of potent IMPDH inhibitor with immunosuppressive and antiarthritic activity

May 27, 2002

BMS describes novel series for immune and inflammatory disorders

May 27, 2002

15-LO inducers and their use in inflammatory and autoimmune disorders

May 27, 2002

RPR-238677 identified as a potent, orally available p38 MAP kinase inhibitor

May 24, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...